BEAM vs ILMN · rev $63.5M vs rev $4.34B
Beam Therapeutics Inc (BEAM) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported ILMN revenue for 2025-12-28 was $4.34B. Net income was $850.0M. Revenue was down 0.7% from 2024-12-29 to 2025-12-28. ILMN currently screens at market cap $15.84B.
BEAM currently screens at market cap $2.01B. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the BEAM and ILMN stock pages for the full models.
Not investment advice.